摘要
目的:探讨十全大补汤加减治疗难治性心衰的临床疗效及安全性。方法:本次研究选择的对象共78例,均为2010年1月-2012年10月我院确诊的各类难治性心衰患者,按入院顺序随机分为治疗组和对照组各39例,两组均给予休息、限盐、利尿、抗感染、吸氧、洋地黄等常规治疗,对照组在此基础上加用硝普纳静脉滴注;治疗组在对照组治疗基础上应用十全大补汤加减治疗。7d后评价两组患者的心功能改善情况、临床症状改善总有效率以及不良反应。结果:治疗组临床治疗有效率92.31%明显高于对照组的79.49%,差异有统计学意义(P<0.05);治疗组在治疗后的心功能指标改善情况均明显优于对照组(P均<0.05),差异均有统计学意义。两组均未见明显不良反应。结论:十全大补汤加减治疗能明显改善RHF患者的心功能,提高生活质量,且毒副作用小,值得临床推广应用。
Objective:To investigate clinical efficacy and safetyof the Shiquan Dabu decoction for refractory heart failure. Methods:78 cases were divided into treatment group and control group 39 cases, both groups were given conventional treatment, the control group was given sodium nitroprusside infusion; the Shiquan Dabu decoction were added in the treatment group. Clinical treatment group had significantly higher efficiency of 92.31% than 79.49%, the difference was statistically significant (P〈0.05); treatment group improving cardiac function after treatment were significantly better than the control case group (P〈0.05). Conclusion:the Shiquan Dabu decoction for RHF significantly improved cardiac function, and is worthy of clinical application.
出处
《中医临床研究》
2015年第7期104-105,共2页
Clinical Journal Of Chinese Medicine
关键词
十全大补汤加减
难治性心衰
临床疗效
安全性
The Shiquan Dabu decoction
Refractory heart failure
Clinical efficacy
Safety